Feed de notíciasFeed de notíciashttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/rss2026-10-31T17:43:25Z2026-10-31T17:43:25ZPrescrição e dispensa da vacina contra a gripe em farmácia comunitáriaTeresa Canelhashttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/137536402026-10-30T19:17:41Z2026-10-30T19:08:00ZTeresa Canelhas2026-10-30T19:08:00ZFórum Incluir debate participação das pessoas com doença na investigação clínicaNuno Noronhahttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/137528342026-10-30T17:31:04Z2026-10-30T17:18:00ZNuno Noronha2026-10-30T17:18:00Z<em>Deep Dive</em> | Infarmed lança nova publicação mensal sobre a utilização de medicamentos e outros produtos de saúde em Portugalpaula Magalhães magalhaeshttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/137082672026-10-30T11:37:37Z2026-10-23T10:27:00Zpaula Magalhães magalhaes2026-10-23T10:27:00ZInfarmed reúne Conselho Consultivo para debater prioridades estratégicasNuno Noronhahttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/137327272026-10-29T13:05:57Z2026-10-29T12:40:00ZNuno Noronha2026-10-29T12:40:00ZMonoprost Duo, 0.01 mg/0.2 ml + 1 mg/0.2 ml, colírio, solução em recipiente unidose - Autorização de utilização de lotes rotulados em língua estrangeiracelia ramalhetehttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/137284722026-10-28T10:56:15Z2026-10-26T16:00:00Zcelia ramalhete2026-10-26T16:00:00ZInfarmed divulga indicadores de julho de 2026rui fragosohttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/134973402026-10-22T07:44:15Z2026-08-19T10:01:00Zrui fragoso2026-08-19T10:01:00ZInfarmed divulga indicadores de setembro de 2026rui fragosohttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/137022422026-10-22T07:43:51Z2026-10-20T15:58:00Zrui fragoso2026-10-20T15:58:00ZSistema de Preços de Referência | Aditamento de novos grupos homogéneos (4.º trimestre de 2026)João Domingoshttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/137006412026-10-21T16:48:24Z2026-10-20T07:04:00ZJoão Domingos2026-10-20T07:04:00ZIsturisa (Osilodrostate) Relatório de avaliação de financiamento público disponível na Infomed | Desistência do pedido de avaliação préviapaula pinheirohttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/137026792026-10-21T16:07:20Z2026-10-21T10:58:00Zpaula pinheiro2026-10-21T10:58:00ZAceda à mais recente edição da Infarmed NewsletterHugo Grilohttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/137037052026-10-21T14:30:04Z2026-10-21T14:27:00ZHugo Grilo2026-10-21T14:27:00ZAceda à mais recente edição da Infarmed NewsletterHugo Grilohttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/136602122026-10-21T14:20:54Z2026-10-02T14:40:00ZHugo Grilo2026-10-02T14:40:00ZCessação de comercialização do medicamento Nolotil, metamizol magnésico, 2000 mg/5 ml, solução injetávelpedro silvahttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/136931542026-10-19T15:27:12Z2026-10-16T10:55:00Zpedro silva2026-10-16T10:55:00Z20 anos do Estatuto do Medicamento: Infarmed e APJF promovem debate sobre a evolução e futuro do setorNuno Noronhahttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/136950472026-10-17T10:43:04Z2026-10-17T09:46:00ZNuno Noronha2026-10-17T09:46:00ZAtualização das listas previstas no Regulamento sobre o controlo de transações de medicamentos para o exterior do país (outubro 2026)laura leitehttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/136944062026-10-16T15:41:59Z2026-10-16T15:37:00Zlaura leite2026-10-16T15:37:00ZSarclisa (isatuximab) | Relatórios de avaliação de financiamento público | Deferimentopaula pinheirohttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/136723552026-10-15T16:09:32Z2026-10-14T14:57:00Zpaula pinheiro2026-10-14T14:57:00ZO Infarmed está a recrutar!pedro silvahttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/136725102026-10-14T17:01:27Z2026-10-14T15:24:00Zpedro silva2026-10-14T15:24:00ZInfarmed mobiliza parceiros para impulsionar investigação clínica em PortugalNuno Noronhahttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/136699922026-10-12T13:34:16Z2026-10-12T13:15:00ZNuno Noronha2026-10-12T13:15:00ZRinvoq (Upadacitinib) | Relatórios de avaliação de financiamento público disponível na Infomed | Deferimentopaula pinheirohttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/136679312026-10-09T16:44:21Z2026-10-09T08:26:00Zpaula pinheiro2026-10-09T08:26:00ZArexvy (vacina contra o vírus sincicial respiratório (recombinante, adjuvada)) | Relatório de avaliação de financiamento público disponível na Infomed | Deferimentopaula pinheirohttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/136667622026-10-08T17:31:04Z2026-10-08T14:02:00Zpaula pinheiro2026-10-08T14:02:00ZO Infarmed está a recrutar!Teresa Canelhashttps://www.infarmed.pt/web/infarmed/rss-noticias/-/asset_publisher/zQws9cSRmjar/content/id/136672352026-10-08T17:05:43Z2026-10-08T16:54:00ZTeresa Canelhas2026-10-08T16:54:00Z